The inaugural Spatial Biology for Immuno-Oncology Summit runs at a crucial moment in time. Spurred on by technological advancement and successful case studies, spatial technologies are set to become increasingly mainstream and accessible. If you’re not already, now is the time to harness spatial technologies to power your immunotherapy research, improve your clinical trials, enhance your biomarker discovery, and streamline your therapeutic development.

Uniting researchers, technology providers, and drug developers, next January join your peers to hear the latest best-practice case studies on operationalizing technology, integrating spatial into the clinic, and developing a robust data analysis pipeline. This meeting will provide an unrivaled opportunity to solve your current spatial challenges to improve your ability to treat disease and identify drug targets in immuno-oncology.

Across 3 jam-packed days of content, led by 20+ immuno-oncology leaders, the Spatial Biology for Immuno-Oncology Summit is your only chance to discover how technologies that put omics and single-cell information in spatial context can improve your ability to treat disease and identify drug targets in immuno-oncology.

Join over 100 key industry stakeholders as they gather and leave no stone unturned to advance the application of this revolutionary technology.